Investigation of the antidiabetic actions and function of insulin, glucagon and glucagon-like peptide 1 secreting cells for transplantation therapy of diabetes
Diabetic patients who cannot adequately maintain glucose homeostasis using other agents often have to rely on exogenous insulin treatment. This can have side effects such as hypoglycaemia. Islet transplantation has been shown to provide improved glucose management with lower risk of hypoglycaemia in...
Main Author: | Green, Alastair David |
---|---|
Published: |
Ulster University
2015
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.676526 |
Similar Items
-
Pro-glucagon derived peptide therapies for type 2 diabetes and obesity
by: Bhat, Kattathila Vikas
Published: (2014) -
Glucagon in hyperandrogenic women : relationships to abnormalities of insulin
by: Golland, Ian Morris
Published: (1992) -
G-protein coupled receptors expressed by islet cells modulate glucagon as well as insulin secretion in type 2 diabetes
by: Gormley, Noella Marie
Published: (2016) -
The potential of novel glucagon receptor antagonists alone and in combination with other peptides for the treatment of diabetes
by: McShane, Laura Majella
Published: (2013) -
Aspects of insulin secretion and action in non-insulin-dependent diabetes mellitus
by: Whitelaw, Donald C.
Published: (1999)